CorMedix (CRMD) Assets (2010 - 2026)

CorMedix has reported Assets for 15 years, with the latest figure at $826.1 million in Q4 2025.

• Quarterly Assets rose 595.14% year-over-year to $826.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $826.1 million (up 595.14% YoY) and the FY2025 annual result came in at $826.1 million, up 595.14% from the prior year.
• Assets improved to $826.1 million in Q4 2025 per CRMD's latest filing, from $750.9 million in the prior quarter.
• Over five years, Assets peaked at $826.1 million in Q4 2025 and troughed at $57.0 million in Q2 2023.
• A 5-year average of $157.9 million and a median of $76.5 million in 2021 frame the typical range for Assets.
• The sharpest annual moves came in 2022 and 2025: Assets decreased 22.94% in 2022, then surged 867.78% in 2025.
• Over 5 years, Assets stood at $68.9 million in 2021, then decreased by 10.02% to $62.0 million in 2022, then jumped by 32.27% to $82.1 million in 2023, then jumped by 44.83% to $118.8 million in 2024, then soared by 595.14% to $826.1 million in 2025.
• According to Business Quant data, Assets over the past three periods registered $826.1 million, $750.9 million, and $252.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.